| Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ... Autophagy 12 (1), 1-222, 2016 | 7090 | 2016 |
| VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex KV Lu, JP Chang, CA Parachoniak, MM Pandika, MK Aghi, D Meyronet, ... Cancer cell 22 (1), 21-35, 2012 | 474 | 2012 |
| Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma YL Hu, M DeLay, A Jahangiri, AM Molinaro, SD Rose, WS Carbonell, ... Cancer research 72 (7), 1773-1783, 2012 | 383 | 2012 |
| Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation MK Aghi, BS Carter, GR Cosgrove, RG Ojemann, S Amin-Hanjani, ... Neurosurgery 64 (1), 56-60, 2009 | 338 | 2009 |
| Oncolytic viral therapies–the clinical experience M Aghi, RL Martuza Oncogene 24 (52), 7802-7816, 2005 | 336 | 2005 |
| Impact of extent of resection for recurrent glioblastoma on overall survival O Bloch, SJ Han, S Cha, MZ Sun, MK Aghi, MW McDermott, MS Berger, ... Journal of neurosurgery 117 (6), 1032-1038, 2012 | 325 | 2012 |
| Human glioblastoma–derived cancer stem cells: Establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors H Wakimoto, S Kesari, CJ Farrell, WT Curry, C Zaupa, M Aghi, T Kuroda, ... Cancer research 69 (8), 3472-3481, 2009 | 306 | 2009 |
| Prodrug activation enzymes in cancer gene therapy M Aghi, F Hochberg, XO Breakefield The journal of gene medicine 2 (3), 148-164, 2000 | 236 | 2000 |
| Biology of angiogenesis and invasion in glioma MC Tate, MK Aghi Neurotherapeutics 6 (3), 447-457, 2009 | 211 | 2009 |
| Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes M Aghi, KS Cohen, RJ Klein, DT Scadden, EA Chiocca Cancer research 66 (18), 9054-9064, 2006 | 210 | 2006 |
| Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group MA Vogelbaum, S Jost, MK Aghi, AB Heimberger, JH Sampson, PY Wen, ... Neurosurgery 70 (1), 234-244, 2012 | 185 | 2012 |
| Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy CM Kramm, M Chase, U Herrlinger, A Jacobs, PA Pechan, NG Rainov, ... Human gene therapy 8 (17), 2057-2068, 1997 | 182 | 1997 |
| Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies M Aghi, TC Cho, EA Chiocca, CM Kramm, XO Breakefield JNCI: Journal of the National Cancer Institute 90 (5), 370-380, 1998 | 172 | 1998 |
| Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine/rat cytochrome P450 2B1 and ganciclovir/herpes simplex virus thymidine … M Aghi, TC Chou, K Suling, XO Breakefield, EA Chiocca Cancer research 59 (16), 3861-3865, 1999 | 168 | 1999 |
| Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance A Jahangiri, M De Lay, LM Miller, WS Carbonell, YL Hu, K Lu, MW Tom, ... Clinical Cancer Research 19 (7), 1773-1783, 2013 | 167 | 2013 |
| Tumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapy YL Hu, A Jahangiri, M DeLay, MK Aghi Cancer research 72 (17), 4294-4299, 2012 | 165 | 2012 |
| Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication M Aghi, S Rabkin, RL Martuza Journal of the National Cancer Institute 98 (1), 38-50, 2006 | 150 | 2006 |
| Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging RF Barajas Jr, JJ Phillips, R Parvataneni, A Molinaro, E Essock-Burns, ... Neuro-oncology 14 (7), 942-954, 2012 | 146 | 2012 |
| Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial O Bloch, CA Crane, Y Fuks, R Kaur, MK Aghi, MS Berger, NA Butowski, ... Neuro-oncology 16 (2), 274-279, 2014 | 140 | 2014 |
| New advances that enable identification of glioblastoma recurrence I Yang, MK Aghi Nature Reviews Clinical Oncology 6 (11), 648, 2009 | 132 | 2009 |
